Identification of Sumoylation Sites in CCDC6, the First Identified RET Partner Gene in Papillary Thyroid Carcinoma, Uncovers a Mode of Regulating CCDC6 Function on CREB1 Transcriptional Activity

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Luise, Chiara ^a   Merolla, Francesco ^a   Leone, Vincenza ^a   Paladino, Simona ^a,b   Sarnataro, Daniela ^a,b   Fusco, Alfredo ^a   Celetti, Angela ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CCDC6 PROTEIN; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; FORSKOLIN; SCAFFOLD PROTEIN; SUMO 1 PROTEIN; SUMO 2 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CCDC6 GENE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOSOL; GENE; GENE REPRESSION; HUMAN; HUMAN CELL; NONHUMAN; ONCOGENE RET; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION; SUMOYLATION; THYROID CELL; THYROID PAPILLARY CARCINOMA; TRANSCRIPTION REGULATION;

ANIMALS; CARCINOMA; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; CYTOSKELETAL PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HELA CELLS; HUMANS; LYSINE; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-RET; RATS; SUMOYLATION; THYROID NEOPLASMS; TRANSCRIPTION, GENETIC;

VERTEBRATA;

EID: 84868684272     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049298     Document Type: Article

References (55)

1. Grieco M, Santoro M, Berlingieri MT, Melillo RM, Donghi R, et al. (1990) PTC is a novel rearranged form of the RET proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Cell 60: 557-563.
2. Kondo T, Ezzat S, Asa SL, (2006) Pathogenetic mechanisms in thyroid follicular-cell neoplasia. Nat Rev Cancer 6: 292-306.
3. Santoro M, Dathan NA, Berlingieri MT, Bongarzone I, Paulin C, et al. (1994) Molecular characterization of RET/PTC 3: a novel rearranged version of the RET proto-oncogene in a human thyroid papillary carcinoma. Oncogene 9: 509-516.
4. Santoro M, Melillo RM, Fusco A, (2006) RET/PTC activation in papillary thyroid carcinoma. Eur J Endocrinol 155: 645-653.
5. Pierotti MA, Santoro M, Jenkins RB, Sozzi G, Bongarzone I, et al. (1992) Characterization of an inversion on the long arm of chromosome 10 juxtaposing D10S170 and RET and creating the oncogenic sequence RET/PTC. Proc Natl Acad Sci USA 89: 1616-1620.
6. Takeuchi K, Soda M, Togashi Y, Suzuki R, Sakata S, et al. (2012) RET, ROS1 and ALK fusions in lung cancer. Nat Med 18: 378-81.
7. Drechsler M, Hildebrandt B, Kundgen A, Germing U, Royer-Pokora B, (2007) Fusion of H4/D10S170 to PDGFRbeta in a patient with chronicmyelomonocytic leukemia and long-term responsiveness to imatinib. Ann Hematol 86: 353-354.
8. Puxeddu E, Zhao G, Stringer JR, Medvedovic M, Moretti S, et al. (2005) Characterization of novel non-clonal intrachromosomal rearrangements between the H4 and PTEN genes (H4/PTEN) in human thyroid cell lines and papillary thyroid cancer specimens. Mutat Res 570: 17-32.
9. Grieco M, Cerrato A, Santoro M, Fusco A, Melillo RM, et al. (1994) Cloning and characterization of H4 (D10S170), a gene involved in RET rearrangements in vivo. Oncogene 9: 2531-5.
10. Tong Q, Xing S, Jhiang SM, (1997) Leucine zipper-mediated dimerization is essential for the PTC1 oncogenic activity. J Biol Chem. 272: 9043-7.
11. Jhiang SM, (2000) The RET proto-oncogene in human cancers. Oncogene. 19: 5590-7.
12. Beausoleil SA, Jedrychowski M, Schwartz D, Elias JE, Villén J, et al. (2004) Large-scale characterization of HeLa cell nuclear phosphoproteins. Proc Natl Acad Sci USA. 101: 12130-5.
13. Brill LM, Salomon AR, Ficarro SB, Mukherji M, Stettler-Gill M, et al. (2004) Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry Anal Chem. 76: 2763-72.
14. Celetti A, Cerrato A, Merolla F, Vitagliano D, Vecchio G, et al. (2004) H4(D10S170), a gene frequently rearranged with RET in papillary thyroid carcinomas: functional characterization. Oncogene 23: 109-21.
15. Merolla F, Pentimalli F, Pacelli R, Vecchio G, Fusco A, et al. (2007) Involvement of H4(D10S170) protein in ATM-dependent response to DNA damage. Oncogene. 26: 6167-75.
16. Merolla F, Luise C, Muller MT, Pacelli R, Fusco A et al. (2012) Loss of CCDC6, the first identified RET partner gene, affects pH2AX S139 levels and accelerates mitotic entry upon DNA damage. PLos ONE, 7(5), Epub 2012 May 24.
17. Leone V, Mansueto G, Pierantoni GM, Tornincasa M, Merolla F, et al. (2010) CCDC6 represses CREB1 activity by recruiting histone deacetylase 1 and protein phosphatase 1. Oncogene. 29: 4341-51.
18. Geiss-Friedlander R, Melchior F, (2007) Concepts in sumoylation: a decade on. Nat Rev Mol Cell Biol. 8: 947-56.
19. Gill G, (2004) SUMO and ubiquitin in the nucleus: different functions, similar mechanisms? Genes Dev. 18: 2046-59.
20. Hay RT, (2005) SUMO: a history of modification. Mol Cell 1 18: 1-12.
21. Johnson ES, (2004) Protein modification by SUMO. Annu Rev Biochem. 73: 355-82.
22. Ayaydin F, Dasso M, (2004) Distinct in vivo dynamics of vertebrate SUMO paralogues. Mol Biol Cell. 15: 5208-18.
23. Saitoh H, Hinchey J, (2000) Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3 J Biol Chem. 275: 6252-8.
24. Vertegaal AC, Andersen JS, Ogg SC, Hay RT, Mann M, et al. (2006) Distinct and overlapping sets of SUMO-1 and SUMO-2 target proteins revealed by quantitative proteomics. Mol Cell Proteomics. 5: 2298-310.
25. Gill G, (2003) Post-translational modification by the small ubiquitin-related modifier SUMO has big effects on transcription factor activity Curr Opin Genet Dev. 13: 108-13.
26. Girdwood DW, Tatham MH, Hay RT, (2004) SUMO and transcriptional regulation Semin Cell Dev Biol. 15: 201-10.
27. Ji Z, Degerny C, Vintonenko N, Deheuninck J, Foveau B, et al. (2007) Regulation of the Ets-1 transcription factor by sumoylation and ubiquitinylation. Oncogene 26: 395-406.
28. Fusco A, MT Berlingieri, PP DiFiore, M Grieco, G Portella, et al. (1985) Epithelial transformation by newly isolated murine retroviruses, p. 17-23. In G. Giraldo (ed.), From oncogenes to tumor antigens. Elsevier SciencePublishers, Amsterdam. ISBN 0444806725 9780444806727.
29. Fusco A, Berlingieri MT, Di Fiore PP, Portella G, Grieco M, Vecchio G, (1987) One- and two-step transformations of rat thyroid epithelial cells by retroviral oncogenes. Mol Cell Biol. 9: 3365-70.
30. Berlingieri MT, Portella G, Grieco M, Santoro M, Fusco A, (1988) Cooperation between the polyomavirus middle-T-antigen gene and the human c-myc oncogene in a rat thyroid epithelial differentiated cell line: model of in vitro progression. Mol Cell Biol. 8: 2261-6.
31. Fabien N, Fusco A, Santoro M, Barbier Y, Dubois PM, et al. (1994) Description of a human papillary thyroid carcinoma cell line. Morphologic study and expression of tumoral markers. Cancer 73: 2206-2212.
32. Vertegaal AC, Ogg SC, Jaffray E, Rodriguez MS, Hay RT, et al. (2004) A proteomic study of SUMO-2 target proteins. J Biol Chem. 279: 33791-8.
33. Degerny C, Monte D, Beaudoin C, Jaffray E, Portois L, et al. (2005) SUMO modification of the Ets-related transcription factor ERM inhibits its transcriptional activity. J Biol Chem. 280: 24330-8.
34. Kenworthy AK, Edidin M, (1999) Imaging fluorescence resonance energy transfer as probe of membrane organization and molecular associations of GPI-anchored proteins. Methods Mol Biol. 116: 37-49.
35. Pierantoni GM, Rinaldo C, Esposito F, Mottolese M, Soddu S, et al. (2006) High Mobility Group A1 (HMGA1) proteins interact with p53 and inhibit its apoptotic activity. Cell Death Differ. 13: 1554-63.
36. De Martino I, Visone R, Wierinckx A, Palmieri D, Ferraro A, et al. (2009) HMGA proteins up-regulate CCNB2 gene in mouse and human pituitary adenomas Cancer Res. 69: 1844-50.
37. De Angelis R, Iezzi S, Bruno T, Corbi N, Di Padova M, et al. (2003) Functional interaction of the subunit 3 of RNA polymerase II (RPB3) with transcription factor-4 (ATF4). FEBS Lett. 547: 15-9.
38. Berasain C, Castillo J, Perugorría MJ, Prieto J, Avila MA, (2007) Amphiregulin: a new growth factor in hepatocarcinogenesis. Cancer Lett. 254: 30-4.
39. Comerford KM, Leonard MO, Karhausen J, Carey R, Colgan SP, et al. (2003) Small ubiquitin-related modifier-1 modification mediates resolution of CREB-dependent responses to hypoxia. Proc Natl Acad Sci U S A. 100: 986-91.
40. Shih HM, Chang CC, Kuo HY, Lin DY, (2007) Daxx mediates SUMO-dependent transcriptional control and subnuclear compartmentalization. Biochem Soc Trans. 35: 1397-400.
41. Li X, Vadrevu S, Dunlop A, Day J, Advant N, et al. (2010) Selective SUMO modification of cAMP-specific phosphodiesterase-4D5 (PDE4D5) regulates the functional consequences of phosphorylation by PKA and ERK. Biochem J. 428: 55-65.
42. Cheng J, Wang D, Wang Z, Yeh ET, (2004) SENP1 enhances androgen receptor-dependent transcription through desumoylation of histone deacetylase 1. Mol Cell Biol. 24: 6021-8.
43. Garcia-Dominguez M, Reyes JC, (2009) SUMO association with repressor complexes, emerging routes for transcriptional control. Biochim Biophys Acta. 1789: 451-9.
44. Kim YP, Jin Z, Kim E, Park S, Oh YH, et al. (2009) Analysis of in vitro SUMOylation using bioluminescence resonance energy transfer (BRET). Biochem Biophys Res Commun. 382: 530-4.
45. Martin SF, Tatham MH, Hay RT, Samuel ID, (2008) Quantitative analysis of multi-protein interactions using FRET: application to the SUMO pathway. Protein Sci 17: 777-84.
46. Dohmen RJ, (2004) SUMO protein modification. Biochim Biophys Acta. 1695: 113-3144.
47. Seeler JS, Dejean A (2003) Nuclear and unclear functions of SUMO Nat Rev Mol Cell Biol. 4 690-699.
48. Kimura T, Van Keymeulen A, Golstein J, Fusco A, Dumont JE, et al. (2001) Regulation of thyroid cell proliferation by TSH and other factors: acritical evaluation of in vitro models. Endocr Rev. 22: 631-56.
49. Yeung-Tung Siu, Dong-Yan Jin, (2007) CREB a real culprit in oncogenesis FEBS Journal. 274: 3224-3232.
50. Muller S, Ledl A, Schmidt D, (2004) SUMO: a regulator of gene expression and genome integrity. Oncogene. 23: 1998-2008.
51. Desterro JM, Rodriguez MS, Hay RT, (1998) SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation. Mol Cell 2: 233-239.
52. Hoege C, Pfander B, Moldovan GL, Pyrowolakis G, Jentsch S, (2002) RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO. Nature. 419: 135-41.
53. Yang SH, Sharrocks AD, (2010) MAP Kinase: SUMO pathway interactions. Methods Mol Biol. 661: 343-67.
54. Haymart MR, Repplinger DJ, Leverson GE, Elson DF, Sippel RS, et al. (2008) Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage. J Clin Endocrinol Metab 93: 809-814.
55. Franco AT, Malaguarnera R, Refetoff S, Liao XH, Lundsmith E, et al. (2011) Thyrotrophin receptor signaling dependence of Braf-induced thyroid tumor initiation in mice. Proc Natl Acad Sci U S A. 108: 1615-20.